Replies to post #117 on Tyme Technologies Inc. (TYME)

[Inoviorulez]

THe reason why it didnt' is because there was no disclosure of upfront money or costs. The main events would be the initiations of the 2 upcoming pivotal studies starting. I think these events will drive volume. Then the prostate cancer data should also. Then the preclinical data for 15 cancers.